Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Rejuvenate Bio

Rejuvenate Bio Announces $6 Million Financing and Strategic R&D Collaboration with Merck Animal Health

June 08, 2026

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)

July 01, 2024

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

April 22, 2024

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Announces Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in the Journal Cellular Reprogramming

February 22, 2024

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis

February 14, 2024

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy

October 09, 2023

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Announces Data for Gene Therapy RJB-01 in Mitral Valve Disease at 2023 Meeting of the American Society of Gene and Cell Therapy (ASGCT)

May 18, 2023

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Announces New Preclinical Research Evaluating Cellular Reprogramming for Age Reversal

January 09, 2023

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Appoints Deborah Ascheim, M.D., as Chief Medical Officer

January 03, 2023

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Launches New Office in San Diego

November 07, 2022

From Rejuvenate Bio

Via Business Wire

Rejuvenate Bio Announces Expansion of Scientific Advisory Board

October 03, 2022

From Rejuvenate Bio

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.